Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 41 - 50 of 224 for bayer. (0.13 seconds)

Cancer Drug Reaches Surrogate Endpoint. More details...
CBT 200 Gains 28 Points. More details...
CBT 200 Scores A Win. More details...
Will It Buy Onyx Next?. More details...
CBT 220 Slips 19 Points Lower. More details...
CBT 220 Slips 19 Points Lower. More details...
CBT 200 Gets Positive For 2006. More details...
Nexavar Revenues Beat Estimates. More details...
Joinn Laboratories, a pre-clinical CRO with facilities in...
WuXi Biologics signed a long-term lease for a German...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here